8-K
filed December 13, 2022, 6:59 PM ET
ticker QDEL
CIK 0001906324
leadership
confidence high
sentiment neutral
materiality 0.55
QuidelOrtho appoints Kenneth Buechler as non-executive Chairman; Bryant remains CEO and becomes President
QuidelOrtho Corp
- Kenneth Buechler, Lead Independent Director, appointed non-executive Chairman effective Dec 11, 2022.
- Douglas Bryant remains CEO and adds President role; Robert Bujarski and Michael Iskra appointed EVPs.
- PSUs of ~$500k each (6,091 shares) granted to Bryant, Bujarski, Iskra; vesting by Dec 2025.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael S. Iskra was appointed as Executive Vice President at QuidelOrtho Corp.
- Action
- appointed
- Role
- Executive Vice President
Exact text from the filing
Additionally, Mr. Bujarski, Chief Operating Officer, and Michael S. Iskra, Chief Commercial Officer, have both been appointed Executive Vice Presidents, in addition to continuing to serve in their existing leadership roles.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Douglas C. Bryant was appointed as President at QuidelOrtho Corp.
- Action
- appointed
- Role
- President
Exact text from the filing
The Board also appointed Mr. Bryant to serve, and succeed Robert J. Bujarski, as President of the Company, in addition to Mr. Bryant’s current role as Chief Executive Officer and a member of the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Robert J. Bujarski was appointed as Executive Vice President at QuidelOrtho Corp.
- Action
- appointed
- Role
- Executive Vice President
Exact text from the filing
Additionally, Mr. Bujarski, Chief Operating Officer, and Michael S. Iskra, Chief Commercial Officer, have both been appointed Executive Vice Presidents, in addition to continuing to serve in their existing leadership roles.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Kenneth F. Buechler was appointed as Chairman of the Board at QuidelOrtho Corp.
- Action
- appointed
- Role
- Chairman of the Board
Exact text from the filing
the Company’s Board of Directors (the “Board”) appointed Kenneth F. Buechler, Lead Independent Director, to serve, and succeed Douglas C. Bryant, as the Chairman of the Board (the “Chairman”).
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
QuidelOrtho Corp: Board adopted an amendment and restatement of the Company’s Amended and Restated Bylaws, updating procedural and disclosure requirements for director nominations and business proposals, proxy card color requirements, and other updates (effective 2022-12-08).
- Change
- bylaw amendment
- Effective
- 2022-12-08
Exact text from the filing
On December 8, 2022, as part of its periodic review of corporate governance matters and in connection with the new U.S. Securities and Exchange Commission rules regarding universal proxy cards and certain recent amendments to the Delaware General Corporation Law (the “DGCL”), the Board adopted an amendment and restatement of the Company’s Amended and Restated Bylaws (as so amended and restated, the “Amended and Restated Bylaws”), effective as of such date, in order to, among other things:
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.